Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia

Stroke

Volumn 31, Issue 6, 2000, Pages 1386-1392

  Wang, Yang ^b   Hu, Weixing ^b   Perez Trepichio, Alejandro D ^b   Ng, Thian C ^b   Furlan, Anthony J ^b   Majors, Anthony W ^b   Jones, Stephen C ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cerebral blood flow; Cerebral ischemia; Diffusion weighted; Magnetic resonance, imaging; Middle cerebral artery occlusion; Rats; Sodium; Stroke

Indexed keywords

SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; MIDDLE CEREBRAL ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STROKE;

EID: 0034085157     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.6.1386     Document Type: Article

References (38)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: PROlyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
3. Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M, PROACT Investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11.
4. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study: a randomized controlled trial: Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282: 2019-2026.
5. Wester P, Radberg J, Lundgren B, Peltonen M, The Seek-Medical-Attention-in-Time Study Group. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study. Stroke. 1999;30:40-48.
6. Fogelholm R, Murros K, Rissanen A, Ilmavirta M. Factors delaying hospital admission after acute stroke. Stroke. 1996;27:398-400.
7. Barsan WG, Brott TG, Broderick JP, Haley EC, Levy DE, Marier JR. Time of hospital presentation in patients with acute stroke. Arch Intern Med. 1993;153:2558-2561.
8. Schuier FJ, Hossmann KA. Experimental brain infarcts in cats, II: ischemic brain edema. Stroke. 1980;11:593-601.
9. Thulborn KR, Gindin TS, Davis D, Erb P. Comprehensive MRI protocol for stroke management: tissue sodium concentration as a measure of tissue viability in non-human primate studies and in clinical studies. Radiology. 1999;213:156-166.
10. Perez-Trepichio AD, Xue M, Ng TC, Majors AW, Furlan AJ, Awad IA, Jones SC. Sensitivity of magnetic resonance diffusion-weighted imaging and regional relationship between the apparent diffusion coefficient and CBF in rat focal cerebral ischemia. Stroke. 1995;26:667-675.
11. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 1986;17:738-743.
12. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401-407.
13. 14C in awake cats. J Appl Physiol. 1969;27:296-300.
14. 14C]antipyrine. Am J Physiol. 1978;234:H59-H66.
15. Hu W, Kharlamov A, Wang Y, Perez-Trepichio AD, Jones SC. Directed sampling for electrolyte analysis and water content of micro-punch samples shows large differences between normal and ischemic rat brain cortex. Brain Res. In press.
16. SAS Institute. SAS/STAT User's Guide, Version 6, Volume 2. Cary, NC: SAS Institute, Inc; 1989.
17. Neter J, Wasserman W, Kutner MH. Multiple regression with two independent variables. In: Applied Linear Statistical Models: Regression, Analysis of Variance, and Experimental Designs. Homewood, Ill: RD Irwin; 1985:234-246.
18. 2 and cerebral hemodynamics. Am J Physiol. 1964;206:25-35.
19. 2 reactivity and heterogeneity of cerebral blood flow in ischemic, border zone and normal cortex. Am J Physiol. 1989;257:H473-H482.
20. Perez-Trepichio AD, Furlan AJ, Little JR, Jones SC. Hydroxyethyl starch 200/0.5 reduces infarct volume after embolic stroke in rats. Stroke. 1992; 23:1782-1790.
21. Schielke GP, Moises HC, Betz AL. Blood to brain sodium transport and interstitial fluid potassium concentration during early focal ischemia in the rat. J Cereb Blood Flow Metab. 1991;11:466-471.
22. Betz AL, Firth JA, Goldstein GW. Polarity of the blood-brain barrier: distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells. Brain Res. 1980;192:17-28.
23. Morawetz RB, Crowell RH, DeGirolami U, Marcoux FW, Jones TH, Halsey JH. Regional cerebral blood flow thresholds during cerebral ischemia. Fed Proc. 1979;38:2493-2494.
24. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996;16: 53-59.
25. Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab. 1999;19:701-735.
26. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A. 1992;89:212-216.
27. Detre JA, Zhang W, Roberts DA, Silva AC, Williams DS, Grandis DJ, Koretsky AP, Leigh JS. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed. 1994;7:75-82.
28. Villringer A, Rosen BR, Belliveau JW, Ackerman JL, Lauffer RB, Buxton RB, Chao YS, Wedeen VJ, Brady TJ. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med. 1988;6:164-174.
29. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med. 1990;14:249-265.
30. G-Nitro-L-arginine methyl ester modifies the input function measured by dynamic susceptibility contrast magnetic resonance imaging. J Cereb Blood Flow Metab. 1997;17:791-800.
31. Boada FE, Gillen JS, Shen GX, Chang SY, Thulborn KR. Fast three dimensional sodium imaging. Magn Reson Med. 1997;37:706-715.
32. Christensen JD, Barrere BJ, Boada FE, Vevea JM, Thulbom KR. Quantitative tissue sodium concentration mapping of normal rat brain. Magn Reson Med. 1996;36:83-89.
33. Dickinson LD, Betz AL. Attenuated development of ischemic brain edema in vasopressin-deficient rats. J Cereb Blood Flow Metab. 1992; 12:681-690.
34. Young W, Rappaport ZH, Chalif DJ, Flamm ES. Regional brain sodium, potassium, and water changes in the rat middle cerebral artery occlusion model of ischemia. Stroke. 1987;18:751-759.
35. Ito U, Ohno K, Nakamura R, Suganuma F, Inaba Y. Brain edema during ischemia and after restoration of blood flow: measurement of water, sodium, potassium content and plasma protein permeability. Stroke. 1979; 10:542-547.
36. Lo WD, Betz AL, Schielke GP, Hoff JT. Transport of sodium from blood to brain in ischemic brain edema. Stroke. 1987;18:150-157.
37. Betz AL, Keep RF, Beer ME, Ren X. Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J Cereb Blood Flow Metab. 1994;14:29-37.
38. Warner DS, Smith ML, Siesjo BK. Ischemia in normo-and hyperglycemic rats: effects on brain water and electrolytes. Stroke. 1987;18:464-471.